The Latest Cardiac and Vascular News
AMSTERDAM and MUNICH, Aug. 28, 2018 /PRNewswire/ — Royal Philips (NYSE : PHG , AEX: PHIA), a global leader in health technology, today announced that the European Society of Cardiology has incorporated instantaneous wave-free ratio (iFR) into its updated revascularization guidelines. The new guidelines have provided the highest recommendation (class I A) for iFR alongside fractional flow reserve (FFR) […]
JACKSONVILLE, Fla., Aug. 28, 2018 /PRNewswire/ — At the recent 2018 Congress on CVD Prevention held in New Mexico, Amit Khera, MD, MSc, FASPC was named president of the American Society for Preventive Cardiology (ASPC). The ASPCis a national organization of individuals with a dedicated interest in the prevention of cardiovascular disease. Amit Khera, MD, MSc, […]
MUNICH, Aug. 28, 2018 /PRNewswire/ — The Global ETNA-AF programme is a large and comprehensive single non-vitamin K oral anticoagulant (NOAC) repository of real-world data, as part of the Edoxaban Clinical Research Programme, EDOSURE Three snapshot analyses from baseline data add to growing evidence of the use of edoxaban in the real-world […]
DUBLIN and MUNICH – August 28, 2018 – Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures. The study evaluated patients with symptomatic persistent atrial fibrillation (AF) […]
BOSTON–(BUSINESS WIRE)–InfoBionic, a digital health company focused on creating next-generation solutions for ambulatory, cardiac arrhythmia monitoring, today announced an exclusive, strategic agreement with medical device manufacturer BIOTRONIK for U.S. distribution of InfoBionic’s proprietary MoMe® Kardia system, effective immediately. “BIOTRONIK is a trusted technology provider throughout the healthcare industry and we believe that […]
MUNICH, Aug. 27, 2018 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the results of the Phase 3 MARINER and COMMANDER HF (heart failure) studies, which were presented this week at the European Society of Cardiology (ESC) Congress 2018 and simultaneously published in The New England Journal of Medicine. In both studies, there was no […]
KIRKLAND, Wash., Aug. 27, 2018 /PRNewswire/ — Prevencio, Inc. today announces data demonstrating its HART PAD™test accurately diagnoses peripheral artery disease (PAD) in diabetes mellitus (DM) patients, a patient population in which PAD prevalence has traditionally been difficult to assess. Researchers believe these important findings, presented August 25 at the 2018 European Society of Cardiology […]
MUNICH–(BUSINESS WIRE)–Late-breaking data published and presented today confirm that the non-invasive HeartFlow®FFRct Analysis enables physicians to effectively differentiate patients in need of coronary stenting or bypass surgery from those who can be managed with medications alone. The ADVANCE Registry was published in the European Heart Journal (EHJ) and the Aarhus University Hospital […]
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today announced the first implant in conjunction with the Gore ARISE Study of the GORE® Ascending Stent Graft, an investigational device and the only endovascular stent graft specifically designed to treat Type A dissections of the ascending aorta. The successful procedure took place […]
MUNICH, Aug. 27, 2018 /PRNewswire/ — Corvia Medical, Inc., a privately-held company with a first-in-class structural heart device to treat heart failure, today announced one-year follow-up data from the REDUCE LAP-HF I clinical study of its Interatrial Shunt Device (IASD®). The IASD is the world’s first transcatheter device for heart failure with preserved […]
